SCHEMBL17288673

SCHEMBL17288673

CCOC(=O)c1cc(CCCc2ccccc2)on1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
POLB P06746 1/20 0.50
MMP2 P08253 1/20 0.47
BMP1 P13497 1/20 0.47
MAPK1 P28482 2/20 0.46
HSD17B10 Q99714 1/20 0.46
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 3/20 0.45
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
ALOX5 P09917 1/20 0.45
TSHR P16473 2/20 0.44
CYP1A2 P05177 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15932084 0.92 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9APOLBMAPK1
SCHEMBL20020242 0.90 NPC1 (0.48) SMN1; SMN2NPC1RAB9AMAPK1HSD17B10
SCHEMBL15932049 0.87 MAPT (0.53) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL15932063 0.87 SLC26A6 (0.47) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL17288601 0.87 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9APOLBMAPK1
SCHEMBL15931844 0.87 CYP1A2 (0.45) SMN1; SMN2NPC1RAB9APOLBMAPK1
SCHEMBL15932224 0.87 NPC1 (0.45) SMN1; SMN2NPC1RAB9APOLBMMP2
SCHEMBL10318323 0.86 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9APOLBMMP2
SCHEMBL15931787 0.86 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9APOLBMMP2
SCHEMBL15931820 0.86 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9APOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2952096-B1 Amide compound, an arthropod pest control agent and a method for controlling arthropod pest SUMITOMO CHEMICAL CO (JP) 2018-04-04 EP disclosed
US-9814235-B2 Method for controlling arthropod pest SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-14 US disclosed
US-9814235-B2 Method for controlling arthropod pest SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-14 US disclosed
US-9814235-B2 Method for controlling arthropod pest SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-14 US disclosed
EP-2952096-A1 METHOD FOR CONTROLLING ARTHROPOD PEST Sumitomo Chemical Company, Limited (JP) 2015-12-09 EP disclosed
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-12-03 US disclosed
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-12-03 US disclosed
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST H1-0, H1-3, H1-2 SMN1; SMN2 2187/4885NPC1 3630/4885RAB9A 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.